Searchable abstracts of presentations at key conferences in endocrinology

ea0015p311 | Steroids | SFEBES2008

Testosterone increases kidney weight in orchiectomized male Wistar rats but not dihydrotestosterone

Michaelis Marten , Hofmann Peter , Rohde Wolfgang , Goetze Franziska , Quinkler Marcus

Introduction: Androgens are known to play an important role in renal tubular epithelial cell growth, hypertrophy and erythropoetin production, however the exact mechanisms are not clear yet. 5α-dihydrotestosterone is synthesized primarily in gonads and skin, and is the most used androgen in studies. However, little is known about testosterone effects in non-gonadal tissues.Methods: Male Wistar rats aged 8–10 weeks were orchiectomized and put on...

ea0026p568 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Plasma levels of the neurohormones A and B-type natriuretic peptides increases after weight loss in severe obesity

Kistorp C , Christensen R , Goetze J P , Bliddal H , Faber J

Introduction: The neurohormones A and B-type natriuretic peptides are markedly increased in patients with heart disease, and are well established as useful diagnostic biomarkers. Obesity is a known risk factor for cardiovascular disease. Cross sectional data suggest however that plasma levels are reduced among obese. Therefore, the aim of the present study was to investigate the impact of weight loss and corresponding changes in body composition on plasma levels of A and B-typ...

ea0029oc19.5 | Cardiovascular Endocrinology | ICEECE2012

Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients

Holmager P. , Schou M. , Egstrup M. , Gustafsson I. , Goetze J. , Gustafsson F. , Hildebrandt P. , Faber J. , Kistorp C.

Introduction: Heart failure is characterised by an up-regulation of neurohoromones, and brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) are well-established diagnostic biomarkers with substancial prognostic value. Adrenomedullin is a vasoactive peptide and a potential biomarker of vascular injury in patients with cardiovascular disease (CVD) The aims of the present study were to investigate whether mid-regional pro adrenomedullin (MR-proADM) is predictive ...